Catalog: | C0852T |
Product Type: | Test kit |
Unit: | 96 tests |
Regulatory status: | RUO |
Incubation time: | 1 x 1 h, 2 x 30 min |
Standard range: | 12.5 - 800 pg/mL |
Sample type: | Serum, plasma, cell culture supernatant |
Sample requirements: | 100 µL |
Isotope/Substrate: | TMB 450 nm |
Analysis mode: | ELISA |
Application: | Metabolic Syndrome |
The recessive obesity mutation, ob, identified in 1950, results in profound obesity and type II diabetes as part of a syndrome that resembles morbid obesity in humans. Freidman’s group at Rockefeller University originally identified the obesity gene that encodes for Leptin in 1994. Leptin is a 16 KDa secreted protein produced by the ob gene. Adipose tissue produces Leptin and releases it into the bloodstream. As fat deposits grow, blood Leptin levels tends to increase. It has been suggested that Leptin acts as a lipostat, increasing as fat gets deposited into adipocytes. It is also found that the protein acts as a hormone instructing the brain to stop food consumption and to increase activity. The protein has also been shown to signal and probably control the onset of puberty. In addition, recent study shows Leptin acts as a potent inhibitor of bone formation through central nervous system.
Copyright © 2025 Creative Biogene. All rights reserved.